373 filings
Page 7 of 19
8-K
f5v53fd
26 Apr 18
Bristol-Myers Squibb Reports First Quarter Financial Results
12:00am
8-K
v6bena
1 Mar 18
Bristol‑Myers Squibb Names José Baselga, M.D., Ph.D. to Board of Directors
12:00am
8-K
tnk5s6g2q2mfta37k
14 Feb 18
Other Events
12:00am
8-K
uxnq0y6 ybxyyve
5 Feb 18
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
12:00am
8-K
ewo6fuvc
25 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
76dhv9ew su8kk
5 Jan 18
Other Events
12:00am
8-K
gbl8e8 3hv97dh0
26 Oct 17
Bristol-Myers Squibb Reports Third Quarter Financial Results
12:00am
8-K
5xufx0
13 Sep 17
Bristol-Myers Squibb Names Karen Vousden, Ph.D. to Board of Directors
12:00am
8-K
txvcxz92zt7 y994rex
27 Jul 17
Bristol-Myers Squibb Reports Second Quarter Financial Results
12:00am
8-K
rhergckxs34tbe48
14 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
ujngfz65wy wr
14 Jun 17
Bristol-Myers Squibb Announces Cash Tender Offer For Any and All of Certain of Its Outstanding Debt Securities
12:00am
8-K
c1l3wd0i9fmhpk
5 May 17
Departure of Directors or Certain Officers
12:00am
8-K
o6id33 tl
27 Apr 17
Bristol-Myers Squibb Reports First Quarter Financial Results
12:00am
8-K
gfhje dqo54649
23 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
uuiz4i krkq
8 Mar 17
Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer
12:00am
8-K
w3qyly6 627br0jrhjpf
27 Feb 17
Other Events
12:00am
8-K
ue2r4t0l
21 Feb 17
Bristol-Myers Squibb Appoints Three New Independent Directors
12:00am
8-K
6ijeipx4ke sbp5m
26 Jan 17
Bristol-Myers Squibb Reports Fourth Quarter Financial Results
12:00am
8-K
dc5wowu5ib
21 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
b3txneklcz91k01ftmh
4 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am